Risks of heart-valve abnormalities with appetite suppressants

被引：2

作者：

Baird, IM

机构：

来源：

LANCET | 1998年 / 352卷 / 9138期

关键词：

D O I：

10.1016/S0140-6736(05)61258-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1403 / 1404

页数：2

共 11 条

[1] Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment [J].

Cannistra, LB ;

Cannistra, AJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :771-771

[2] Valvular heart disease associated with fenfluramine-phentermine [J].

Connolly, HM ;

Crary, JL ;

McGoon, MD ;

Hensrud, DD ;

Edwards, BS ;

Edwards, WD ;

Schaff, HV .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588

[3] Appetite suppressants and valvular heart disease [J].

Devereux, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :765-767

[4]

GARROW J, 1998, BRIT MED J, V317, P8300

[5] Studies on diet drugs and valve damage disagree [J].

Husten, L .

LANCET, 1998, 352 (9131) :885-885

[6] A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation [J].

Jick, H ;

Vasilakis, C ;

Weinrauch, LA ;

Meier, CR ;

Jick, SS ;

Derby, LE .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :719-724

[7]

JOSEFSON D, 1997, BRIT MED J, V315, P1327

[8] The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs [J].

Khan, MA ;

Herzog, CA ;

St Peter, JV ;

Hartley, GG ;

Madlon-Kay, R ;

Dick, CD ;

Asinger, RW ;

Vessey, JT .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :713-718

[9] Pharmacotherapy for obesity - Do the benefits outweigh the risks? [J].

Manson, JE ;

Faich, GA .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :659-660

[10]

ROBOLIO PA, 1995, CIRCULATION, V92, P980

← 1 2 →